XML 43 R9.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 2 - Revision of Previously Issued Financial Statements for Immaterial Misstatements
12 Months Ended
Dec. 31, 2018
Notes to Financial Statements  
Accounting Changes and Error Corrections [Text Block]
Note
2.
Revision of Previously Issued Financial Statements for Immaterial Misstatements
 
In the
third
quarter of
2018,
we determined accumulated DDA on our consolidated balance sheets and DDA expense on our consolidated statements of operations and comprehensive (loss) income related to Casa Berardi, a business unit within our Hecla Quebec Inc. subsidiary, were understated for the periods from
June 1, 2013
through
June 30, 2018
as a result of errors in calculation from the date of acquisition of Casa Berardi as noted below:
 
 
i.
understatement of DDA by approximately
$35.5
million in the aggregate over
5
1/2
years. The error in calculation resulted from the foreign exchange translation of accumulated DDA and DDA expense from Canadian dollars (“CAD”) to U.S. dollars (“USD”), which was incorrectly set up in the financial reporting system to use the average exchange rate for the respective reporting period, when the historical exchange rate should have been used. The CAD to USD exchange rate at
June 1, 2013
was
0.9646
and has subsequently weakened over the intervening periods, resulting in an understatement of accumulated DDA and DDA expense during the periods from
June 1, 2013
to
June 30, 2018.
 
 
ii.
overstatement of DDA of approximately
$14.2
million in the aggregate over
5
1/2
years related to the accelerated conversion of costs from the mineral interest asset, which represents the value of the undeveloped mineral interest and is
not
depletable, to the mineral properties asset, which represents the value of proven and probable reserves and is depletable. The error in calculation arose from the incorrect use of fair value information available on the per ounce value at the date of acquisition and resulted in the overstatement of the proven and probable reserves asset, which is subject to depletion, and an understatement of the undeveloped mineral interest asset, both of which are categories reported within properties, plants, equipment and mineral interests, net on the balance sheet. The overstatement of the conversions to the proven and probable reserves asset during the periods from
January 1, 2014
through
June 30, 2018
resulted in overstatements of accumulated DDA and DDA expense in each of these periods.
 
We assessed the materiality of the effect of the errors on our prior quarterly and annual financial statements, both quantitatively and qualitatively, in accordance with the SEC’s Staff Accounting Bulletin ("SAB")
No.
99,
“Materiality,” and SAB
No.
108,
“Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements,” and concluded the errors were
not
material to any of our previously issued financial statements. Consequently, we made the decision to correct these errors prospectively and revise our financial statements when the consolidated balance sheets, statements of operations and comprehensive income and cash flows for such prior periods are included in filings made after the
third
quarter of
2018,
including in this report (the "Revisions"). The Revisions had
no
net impact on our sales or net cash provided by operating activities for any period presented.
 
The following tables present a summary of the impact, by financial statement line item, of the Revisions as of and for the years ended
December 31, 2017
and
2016,
and as of
January 1, 2016:
 
   
As of and for the Year Ended December 31, 2017
 
(in thousands)
 
As Previously
Reported
   
Adjustment
   
As Revised
 
Condensed Consolidated Balance Sheet
 
 
 
 
 
 
 
 
 
 
 
 
Inventories: Concentrate, doré, and stockpiled ore
  $
28,455
    $
911
    $
29,366
 
Total current assets
   
320,325
     
911
     
321,236
 
Properties, plants, equipment and mineral interests, net
   
2,020,021
     
(20,710
)
   
1,999,311
 
Total assets
 
 
2,364,957
   
 
(19,799
)
 
 
2,345,158
 
Deferred tax liability
   
121,546
     
2,806
     
124,352
 
Total liabilities
   
881,075
     
2,806
     
883,881
 
Accumulated deficit
   
(195,484
)
   
(22,605
)
   
(218,089
)
Total shareholders' equity
   
1,483,882
     
(22,605
)
   
1,461,277
 
Total liabilities and shareholders' equity
 
 
2,364,957
   
 
(19,799
)
 
 
2,345,158
 
                         
Consolidated Statements of Operations and Comprehensive (Loss) Income
 
 
 
 
 
 
 
 
 
 
 
 
Depreciation, depletion and amortization
  $
116,062
    $
4,537
    $
120,599
 
Total cost of sales
   
420,789
     
4,537
     
425,326
 
Gross profit
   
156,986
     
(4,537
)
   
152,449
 
Income (loss) from operations
 
 
64,643
   
 
(4,537
)
 
 
60,106
 
Foreign exchange (loss) gain
   
(10,300
)
   
620
     
(9,680
)
Total other (expense) income
   
(68,283
)
   
620
     
(67,663
)
(Loss) income before income taxes
 
 
(3,640
)
 
 
(3,917
)
 
 
(7,557
)
Income tax (provision) benefit
   
(19,879
)
   
(1,084
)
   
(20,963
)
Net (loss) income
  $
(23,519
)
  $
(5,001
)
  $
(28,520
)
(Loss) income applicable to common shareholders
 
$
(24,071
)
 
$
(5,001
)
 
$
(29,072
)
Comprehensive income (loss)
   
(12,290
)
   
(5,001
)
   
(17,291
)
Basic (loss) income per common share after preferred dividends
 
$
(0.06
)
 
$
(0.01
)
 
$
(0.07
)
Diluted (loss) income per common share after preferred dividends
 
$
(0.06
)
 
$
(0.01
)
 
$
(0.07
)
                         
Condensed Consolidated Statements of Cash Flows
 
 
 
 
 
 
 
 
 
 
 
 
Net (loss) income
  $
(23,519
)
  $
(5,001
)
  $
(28,520
)
Depreciation, depletion and amortization
   
121,930
     
4,537
     
126,467
 
Foreign exchange loss (gain)
   
10,828
     
(620
)
   
10,208
 
Deferred income taxes
   
18,308
     
1,084
     
19,392
 
 
   
As of and for the Year Ended December 31, 2016
 
(in thousands)
 
As Previously
Reported
   
Adjustment
   
As Revised
 
Condensed Consolidated Balance Sheet
 
 
 
 
 
 
 
 
 
 
 
 
Accumulated deficit
  $
(167,437
)
  $
(17,604
)
  $
(185,041
)
Total shareholders' equity
   
1,479,844
     
(17,604
)
   
1,462,240
 
                         
Consolidated Statements of Operations and Comprehensive (Loss) Income
 
 
 
 
 
 
 
 
 
 
 
 
Depreciation, depletion and amortization
   
116,126
     
7,505
     
123,631
 
Total cost of sales
   
454,451
     
7,505
     
461,956
 
Gross profit
   
191,506
     
(7,505
)
   
184,001
 
Income (loss) from operations
 
 
116,944
   
 
(7,505
)
 
 
109,439
 
Foreign exchange (loss) gain
   
(2,926
)
   
189
     
(2,737
)
Total other (expense) income
   
(19,969
)
   
189
     
(19,780
)
(Loss) income before income taxes
 
 
96,975
   
 
(7,316
)
 
 
89,659
 
Income tax (provision) benefit
   
(27,428
)
   
(662
)
   
(28,090
)
Net (loss) income
  $
69,547
    $
(7,978
)
  $
61,569
 
(Loss) income applicable to common shareholders
 
$
68,995
   
$
(7,978
)
 
$
61,017
 
Comprehensive income (loss)
   
67,576
     
(7,978
)
   
59,598
 
Basic (loss) income per common share after preferred dividends
 
$
0.18
   
$
(0.02
)
 
$
0.16
 
Diluted (loss) income per common share after preferred dividends
 
$
0.18
   
$
(0.02
)
 
$
0.16
 
                         
Condensed Consolidated Statements of Cash Flows
 
 
 
 
 
 
 
 
 
 
 
 
Net (loss) income
  $
69,547
    $
(7,978
)
  $
61,569
 
Depreciation, depletion and amortization
   
117,413
     
7,505
     
124,918
 
Foreign exchange loss (gain)
   
4,649
     
(189
)
   
4,460
 
Deferred income taxes
   
2,112
     
662
     
2,774
 
 
   
As of January 1, 2016
 
(in thousands)
 
As Previously
Reported
   
Adjustment
   
As Revised
 
Consolidated Statements of Changes in Shareholders' Equity
 
 
 
 
 
 
 
 
 
 
 
 
Accumulated deficit
  $
(232,565
)
  $
(9,626
)
  $
(242,191
)
Total shareholders' equity
   
1,338,926
     
(9,626
)
   
1,329,300